PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Dlx5
|
ENSMUSG00000029755.11 | Dlx5 |
Dlx4
|
ENSMUSG00000020871.9 | Dlx4 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Dlx4 | mm39_v1_chr11_-_95037089_95037089 | -0.36 | 1.7e-03 | Click! |
Dlx5 | mm39_v1_chr6_-_6882068_6882092 | -0.03 | 7.8e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_21671571 | 5.97 |
ENSMUST00000217382.2
ENSMUST00000214149.2 ENSMUST00000098942.6 ENSMUST00000216057.2 |
Spc24
|
SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
chr6_+_41107047 | 4.21 |
ENSMUST00000103271.2
|
Trbv13-3
|
T cell receptor beta, variable 13-3 |
chr8_+_23901506 | 4.13 |
ENSMUST00000033952.8
|
Sfrp1
|
secreted frizzled-related protein 1 |
chr1_+_45350698 | 4.00 |
ENSMUST00000087883.13
|
Col3a1
|
collagen, type III, alpha 1 |
chrX_+_106132840 | 4.00 |
ENSMUST00000118666.8
ENSMUST00000053375.4 |
P2ry10
|
purinergic receptor P2Y, G-protein coupled 10 |
chr12_-_114012399 | 3.87 |
ENSMUST00000103468.3
|
Ighv11-2
|
immunoglobulin heavy variable V11-2 |
chr6_-_68713748 | 3.69 |
ENSMUST00000183936.2
ENSMUST00000196863.2 |
Igkv19-93
|
immunoglobulin kappa chain variable 19-93 |
chr9_+_65797519 | 3.39 |
ENSMUST00000045802.7
|
Pclaf
|
PCNA clamp associated factor |
chr16_-_18904240 | 3.34 |
ENSMUST00000103746.3
|
Iglv1
|
immunoglobulin lambda variable 1 |
chr3_-_144514386 | 3.30 |
ENSMUST00000197013.2
|
Clca3a2
|
chloride channel accessory 3A2 |
chr6_-_69204417 | 3.30 |
ENSMUST00000103346.3
|
Igkv4-72
|
immunoglobulin kappa chain variable 4-72 |
chr13_+_51799268 | 3.21 |
ENSMUST00000075853.6
|
Cks2
|
CDC28 protein kinase regulatory subunit 2 |
chr1_+_85538554 | 3.17 |
ENSMUST00000162925.2
|
Sp140
|
Sp140 nuclear body protein |
chr3_-_106126794 | 3.14 |
ENSMUST00000082219.6
|
Chil4
|
chitinase-like 4 |
chr11_-_68291638 | 3.09 |
ENSMUST00000108674.9
|
Ntn1
|
netrin 1 |
chr6_+_68233361 | 3.09 |
ENSMUST00000103320.3
|
Igkv14-111
|
immunoglobulin kappa variable 14-111 |
chr17_+_34457868 | 3.01 |
ENSMUST00000095342.11
ENSMUST00000167280.8 ENSMUST00000236838.2 |
H2-Ob
|
histocompatibility 2, O region beta locus |
chr6_+_70700207 | 3.00 |
ENSMUST00000103407.3
ENSMUST00000199487.2 |
Igkj3
|
immunoglobulin kappa joining 3 |
chr9_-_109455125 | 2.96 |
ENSMUST00000073962.8
|
Fbxw24
|
F-box and WD-40 domain protein 24 |
chr9_-_36637670 | 2.92 |
ENSMUST00000172702.9
ENSMUST00000172742.2 |
Chek1
|
checkpoint kinase 1 |
chr4_-_131802606 | 2.88 |
ENSMUST00000146021.8
|
Epb41
|
erythrocyte membrane protein band 4.1 |
chr2_+_155593030 | 2.85 |
ENSMUST00000029140.12
ENSMUST00000132608.2 |
Procr
|
protein C receptor, endothelial |
chr8_-_4829519 | 2.82 |
ENSMUST00000022945.9
|
Shcbp1
|
Shc SH2-domain binding protein 1 |
chr1_+_152683627 | 2.81 |
ENSMUST00000027754.7
|
Ncf2
|
neutrophil cytosolic factor 2 |
chr6_-_70313491 | 2.77 |
ENSMUST00000103388.4
|
Igkv6-20
|
immunoglobulin kappa variable 6-20 |
chr4_-_131802561 | 2.75 |
ENSMUST00000105970.8
ENSMUST00000105975.8 |
Epb41
|
erythrocyte membrane protein band 4.1 |
chr17_+_34524884 | 2.74 |
ENSMUST00000074557.11
|
H2-Eb1
|
histocompatibility 2, class II antigen E beta |
chr12_-_114355789 | 2.72 |
ENSMUST00000103486.2
|
Ighv6-3
|
immunoglobulin heavy variable 6-3 |
chr7_+_43874752 | 2.72 |
ENSMUST00000075162.5
|
Klk1
|
kallikrein 1 |
chr17_+_34524841 | 2.70 |
ENSMUST00000235530.2
|
H2-Eb1
|
histocompatibility 2, class II antigen E beta |
chr1_+_21419819 | 2.70 |
ENSMUST00000088407.4
|
Khdc1a
|
KH domain containing 1A |
chr11_-_117671436 | 2.69 |
ENSMUST00000026659.10
ENSMUST00000127227.2 |
Tmc6
|
transmembrane channel-like gene family 6 |
chr16_+_22965286 | 2.66 |
ENSMUST00000023593.6
|
Adipoq
|
adiponectin, C1Q and collagen domain containing |
chr3_+_106393348 | 2.65 |
ENSMUST00000183271.2
|
Dennd2d
|
DENN/MADD domain containing 2D |
chr7_+_100145192 | 2.64 |
ENSMUST00000133044.3
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr6_+_41092928 | 2.61 |
ENSMUST00000194399.2
|
Trbv13-1
|
T cell receptor beta, variable 13-1 |
chr12_-_75678092 | 2.60 |
ENSMUST00000238938.2
|
Rplp2-ps1
|
ribosomal protein, large P2, pseudogene 1 |
chr5_-_65855511 | 2.58 |
ENSMUST00000201948.4
|
Pds5a
|
PDS5 cohesin associated factor A |
chr17_+_88748139 | 2.57 |
ENSMUST00000112238.9
ENSMUST00000155640.2 |
Foxn2
|
forkhead box N2 |
chr5_+_138185747 | 2.53 |
ENSMUST00000110934.9
|
Cnpy4
|
canopy FGF signaling regulator 4 |
chr16_-_75706161 | 2.53 |
ENSMUST00000114239.9
|
Samsn1
|
SAM domain, SH3 domain and nuclear localization signals, 1 |
chr14_+_62529924 | 2.52 |
ENSMUST00000166879.8
|
Rnaseh2b
|
ribonuclease H2, subunit B |
chrX_+_133486391 | 2.50 |
ENSMUST00000113211.8
|
Rpl36a
|
ribosomal protein L36A |
chr18_+_44237474 | 2.50 |
ENSMUST00000081271.7
|
Spink12
|
serine peptidase inhibitor, Kazal type 12 |
chr6_+_137731526 | 2.48 |
ENSMUST00000203216.3
ENSMUST00000087675.9 ENSMUST00000203693.3 |
Dera
|
deoxyribose-phosphate aldolase (putative) |
chr6_+_70675416 | 2.42 |
ENSMUST00000103403.3
|
Igkv3-2
|
immunoglobulin kappa variable 3-2 |
chr10_-_128361731 | 2.41 |
ENSMUST00000026427.8
|
Esyt1
|
extended synaptotagmin-like protein 1 |
chr10_-_44024843 | 2.40 |
ENSMUST00000200401.2
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr7_-_79382651 | 2.37 |
ENSMUST00000205413.2
|
Plin1
|
perilipin 1 |
chr10_+_58159288 | 2.35 |
ENSMUST00000020078.14
|
Lims1
|
LIM and senescent cell antigen-like domains 1 |
chr10_-_128640232 | 2.34 |
ENSMUST00000051011.14
|
Tmem198b
|
transmembrane protein 198b |
chr11_-_69786324 | 2.34 |
ENSMUST00000001631.7
|
Acap1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr3_+_145827410 | 2.33 |
ENSMUST00000039450.5
|
Mcoln3
|
mucolipin 3 |
chr3_+_92272486 | 2.31 |
ENSMUST00000050397.2
|
Sprr2f
|
small proline-rich protein 2F |
chr19_-_11582207 | 2.27 |
ENSMUST00000025582.11
|
Ms4a6d
|
membrane-spanning 4-domains, subfamily A, member 6D |
chr16_+_22965330 | 2.25 |
ENSMUST00000171309.2
|
Adipoq
|
adiponectin, C1Q and collagen domain containing |
chr6_+_135339929 | 2.23 |
ENSMUST00000032330.16
|
Emp1
|
epithelial membrane protein 1 |
chr7_+_78922947 | 2.21 |
ENSMUST00000037315.13
|
Abhd2
|
abhydrolase domain containing 2 |
chr6_-_68609426 | 2.19 |
ENSMUST00000103328.3
|
Igkv10-96
|
immunoglobulin kappa variable 10-96 |
chr6_+_48872181 | 2.17 |
ENSMUST00000031835.14
|
Aoc1
|
amine oxidase, copper-containing 1 |
chr1_-_171854818 | 2.14 |
ENSMUST00000138714.2
ENSMUST00000027837.13 ENSMUST00000111264.8 |
Vangl2
|
VANGL planar cell polarity 2 |
chr6_-_69282389 | 2.14 |
ENSMUST00000103350.3
|
Igkv4-68
|
immunoglobulin kappa variable 4-68 |
chr16_-_19079594 | 2.13 |
ENSMUST00000103752.3
ENSMUST00000197518.2 |
Iglv2
|
immunoglobulin lambda variable 2 |
chr6_+_70703409 | 2.11 |
ENSMUST00000103410.3
|
Igkc
|
immunoglobulin kappa constant |
chr9_-_105973975 | 2.09 |
ENSMUST00000121963.3
|
Col6a4
|
collagen, type VI, alpha 4 |
chr1_-_85664246 | 2.07 |
ENSMUST00000064788.14
|
A630001G21Rik
|
RIKEN cDNA A630001G21 gene |
chr3_-_15491482 | 2.03 |
ENSMUST00000099201.9
ENSMUST00000194144.3 ENSMUST00000192700.3 |
Sirpb1a
|
signal-regulatory protein beta 1A |
chr10_+_77905136 | 2.00 |
ENSMUST00000105393.3
|
Icosl
|
icos ligand |
chr4_-_43499608 | 2.00 |
ENSMUST00000136005.3
ENSMUST00000054538.13 |
Arhgef39
|
Rho guanine nucleotide exchange factor (GEF) 39 |
chr9_+_21634779 | 1.99 |
ENSMUST00000034713.9
|
Ldlr
|
low density lipoprotein receptor |
chr9_-_71803354 | 1.99 |
ENSMUST00000184448.8
|
Tcf12
|
transcription factor 12 |
chrX_+_139857640 | 1.98 |
ENSMUST00000112971.2
|
Atg4a
|
autophagy related 4A, cysteine peptidase |
chr19_-_40576817 | 1.96 |
ENSMUST00000175932.2
ENSMUST00000176955.8 ENSMUST00000149476.3 |
Aldh18a1
|
aldehyde dehydrogenase 18 family, member A1 |
chr6_+_41092970 | 1.94 |
ENSMUST00000103268.3
|
Trbv13-1
|
T cell receptor beta, variable 13-1 |
chr14_+_54701594 | 1.93 |
ENSMUST00000022782.10
|
Lrp10
|
low-density lipoprotein receptor-related protein 10 |
chr2_+_69050315 | 1.92 |
ENSMUST00000005364.12
ENSMUST00000112317.3 |
G6pc2
|
glucose-6-phosphatase, catalytic, 2 |
chr6_-_69245427 | 1.92 |
ENSMUST00000103348.3
|
Igkv4-70
|
immunoglobulin kappa chain variable 4-70 |
chr7_-_30523191 | 1.89 |
ENSMUST00000053156.10
|
Ffar2
|
free fatty acid receptor 2 |
chr3_+_93427791 | 1.89 |
ENSMUST00000029515.5
|
S100a11
|
S100 calcium binding protein A11 |
chr9_-_107483855 | 1.89 |
ENSMUST00000073448.12
ENSMUST00000194606.2 ENSMUST00000195662.6 |
Sema3b
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
chr10_-_62363217 | 1.89 |
ENSMUST00000160987.8
|
Srgn
|
serglycin |
chr14_-_59602882 | 1.88 |
ENSMUST00000160425.8
ENSMUST00000095157.11 |
Phf11d
|
PHD finger protein 11D |
chr15_+_25774070 | 1.87 |
ENSMUST00000125667.3
|
Myo10
|
myosin X |
chr2_+_24257576 | 1.85 |
ENSMUST00000140547.2
ENSMUST00000102942.8 |
Psd4
|
pleckstrin and Sec7 domain containing 4 |
chrX_+_139857688 | 1.84 |
ENSMUST00000239541.1
|
Atg4a
|
autophagy related 4A, cysteine peptidase |
chr4_-_136626073 | 1.81 |
ENSMUST00000046285.6
|
C1qa
|
complement component 1, q subcomponent, alpha polypeptide |
chr7_+_43874854 | 1.80 |
ENSMUST00000206144.2
|
Klk1
|
kallikrein 1 |
chr10_-_128579879 | 1.79 |
ENSMUST00000026414.9
|
Dgka
|
diacylglycerol kinase, alpha |
chr12_-_114621406 | 1.79 |
ENSMUST00000192077.2
|
Ighv1-15
|
immunoglobulin heavy variable 1-15 |
chr6_-_13607963 | 1.79 |
ENSMUST00000031554.9
ENSMUST00000149123.3 |
Tmem168
|
transmembrane protein 168 |
chr10_+_26698556 | 1.79 |
ENSMUST00000135866.2
|
Arhgap18
|
Rho GTPase activating protein 18 |
chr6_+_41928559 | 1.78 |
ENSMUST00000031898.5
|
Sval1
|
seminal vesicle antigen-like 1 |
chr6_-_50433064 | 1.77 |
ENSMUST00000146341.4
ENSMUST00000071728.11 |
Osbpl3
|
oxysterol binding protein-like 3 |
chr9_-_36637923 | 1.76 |
ENSMUST00000034625.12
|
Chek1
|
checkpoint kinase 1 |
chr11_-_99482165 | 1.74 |
ENSMUST00000104930.2
|
Krtap1-3
|
keratin associated protein 1-3 |
chr18_+_44237577 | 1.73 |
ENSMUST00000239465.2
|
Spink12
|
serine peptidase inhibitor, Kazal type 12 |
chr9_+_7347369 | 1.73 |
ENSMUST00000005950.12
ENSMUST00000065079.6 |
Mmp12
|
matrix metallopeptidase 12 |
chr6_+_70699822 | 1.73 |
ENSMUST00000198234.2
ENSMUST00000103406.2 |
Igkj2
|
immunoglobulin kappa joining 2 |
chr4_-_41464816 | 1.72 |
ENSMUST00000108055.9
ENSMUST00000154535.8 ENSMUST00000030148.6 |
Kif24
|
kinesin family member 24 |
chr6_-_42622188 | 1.71 |
ENSMUST00000031879.5
|
Tcaf2
|
TRPM8 channel-associated factor 2 |
chr7_-_83384711 | 1.70 |
ENSMUST00000001792.12
|
Il16
|
interleukin 16 |
chr19_-_40576782 | 1.70 |
ENSMUST00000176939.8
|
Aldh18a1
|
aldehyde dehydrogenase 18 family, member A1 |
chr2_+_110427643 | 1.68 |
ENSMUST00000045972.13
ENSMUST00000111026.3 |
Slc5a12
|
solute carrier family 5 (sodium/glucose cotransporter), member 12 |
chr7_-_103094646 | 1.68 |
ENSMUST00000215417.2
|
Olfr605
|
olfactory receptor 605 |
chr2_+_85868891 | 1.68 |
ENSMUST00000218397.2
|
Olfr1033
|
olfactory receptor 1033 |
chr1_+_139382485 | 1.68 |
ENSMUST00000200083.5
ENSMUST00000053364.12 |
Aspm
|
abnormal spindle microtubule assembly |
chr4_+_19818718 | 1.66 |
ENSMUST00000035890.8
|
Slc7a13
|
solute carrier family 7, (cationic amino acid transporter, y+ system) member 13 |
chr1_+_85577766 | 1.65 |
ENSMUST00000066427.11
|
Sp100
|
nuclear antigen Sp100 |
chr17_+_35133435 | 1.65 |
ENSMUST00000007249.15
|
Slc44a4
|
solute carrier family 44, member 4 |
chr15_+_100202079 | 1.64 |
ENSMUST00000230252.2
ENSMUST00000231166.2 |
Mettl7a1
|
methyltransferase like 7A1 |
chr2_-_126342551 | 1.64 |
ENSMUST00000129187.2
|
Atp8b4
|
ATPase, class I, type 8B, member 4 |
chrM_+_7758 | 1.64 |
ENSMUST00000082407.1
|
mt-Atp8
|
mitochondrially encoded ATP synthase 8 |
chr5_-_105198913 | 1.63 |
ENSMUST00000112718.5
|
Gbp8
|
guanylate-binding protein 8 |
chr14_+_54183465 | 1.63 |
ENSMUST00000197130.5
ENSMUST00000103677.3 |
Trdv2-1
|
T cell receptor delta variable 2-1 |
chr19_-_57185861 | 1.62 |
ENSMUST00000111550.8
|
Ablim1
|
actin-binding LIM protein 1 |
chr7_+_140658101 | 1.61 |
ENSMUST00000106039.9
|
Pkp3
|
plakophilin 3 |
chr6_-_16898440 | 1.60 |
ENSMUST00000031533.11
|
Tfec
|
transcription factor EC |
chr19_-_57185988 | 1.60 |
ENSMUST00000099294.9
|
Ablim1
|
actin-binding LIM protein 1 |
chrX_-_47543029 | 1.59 |
ENSMUST00000114958.8
|
Elf4
|
E74-like factor 4 (ets domain transcription factor) |
chr10_+_97400990 | 1.59 |
ENSMUST00000038160.6
|
Lum
|
lumican |
chr6_+_41204430 | 1.58 |
ENSMUST00000193064.2
ENSMUST00000103280.3 |
Trbv26
|
T cell receptor beta, variable 26 |
chr2_+_118644717 | 1.55 |
ENSMUST00000028803.14
ENSMUST00000126045.8 |
Knstrn
|
kinetochore-localized astrin/SPAG5 binding |
chr6_+_135339543 | 1.54 |
ENSMUST00000205156.3
|
Emp1
|
epithelial membrane protein 1 |
chr2_+_85876205 | 1.53 |
ENSMUST00000213496.2
|
Olfr1034
|
olfactory receptor 1034 |
chr7_+_140521450 | 1.53 |
ENSMUST00000164580.3
ENSMUST00000079403.11 |
Pgghg
|
protein glucosylgalactosylhydroxylysine glucosidase |
chr15_+_100202021 | 1.52 |
ENSMUST00000230472.2
|
Mettl7a1
|
methyltransferase like 7A1 |
chr6_-_69553484 | 1.51 |
ENSMUST00000103357.4
|
Igkv4-57
|
immunoglobulin kappa variable 4-57 |
chr14_+_79753055 | 1.51 |
ENSMUST00000110835.3
ENSMUST00000227192.2 |
Elf1
|
E74-like factor 1 |
chr14_-_59602859 | 1.51 |
ENSMUST00000161031.2
|
Phf11d
|
PHD finger protein 11D |
chr9_+_50405817 | 1.50 |
ENSMUST00000114474.8
ENSMUST00000188047.2 |
Plet1
|
placenta expressed transcript 1 |
chr6_-_83010402 | 1.50 |
ENSMUST00000089651.6
|
Dok1
|
docking protein 1 |
chr5_+_76736514 | 1.50 |
ENSMUST00000121979.8
|
Cep135
|
centrosomal protein 135 |
chr12_-_55061117 | 1.49 |
ENSMUST00000172875.8
|
Baz1a
|
bromodomain adjacent to zinc finger domain 1A |
chr10_-_129738595 | 1.48 |
ENSMUST00000071557.2
|
Olfr815
|
olfactory receptor 815 |
chr5_-_87716882 | 1.45 |
ENSMUST00000113314.3
|
Sult1d1
|
sulfotransferase family 1D, member 1 |
chr1_-_149836974 | 1.45 |
ENSMUST00000190507.2
ENSMUST00000070200.15 |
Pla2g4a
|
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
chr14_-_66361931 | 1.45 |
ENSMUST00000070515.2
|
Ephx2
|
epoxide hydrolase 2, cytoplasmic |
chr13_+_19528728 | 1.44 |
ENSMUST00000179181.3
|
Trgc4
|
T cell receptor gamma, constant 4 |
chrX_+_55500170 | 1.44 |
ENSMUST00000039374.9
ENSMUST00000101553.9 ENSMUST00000186445.7 |
Ints6l
|
integrator complex subunit 6 like |
chr18_+_32948436 | 1.44 |
ENSMUST00000025237.5
|
Tslp
|
thymic stromal lymphopoietin |
chr14_-_52341472 | 1.42 |
ENSMUST00000111610.12
ENSMUST00000164655.2 |
Hnrnpc
|
heterogeneous nuclear ribonucleoprotein C |
chr17_+_41121979 | 1.42 |
ENSMUST00000024721.8
ENSMUST00000233740.2 |
Rhag
|
Rhesus blood group-associated A glycoprotein |
chr3_+_79791798 | 1.42 |
ENSMUST00000118853.8
ENSMUST00000145992.2 |
Gask1b
|
golgi associated kinase 1B |
chr13_+_4283729 | 1.42 |
ENSMUST00000081326.7
|
Akr1c19
|
aldo-keto reductase family 1, member C19 |
chr8_+_120426748 | 1.41 |
ENSMUST00000095171.5
ENSMUST00000212454.2 |
Atp2c2
|
ATPase, Ca++ transporting, type 2C, member 2 |
chr14_-_52341426 | 1.40 |
ENSMUST00000227536.2
ENSMUST00000227195.2 ENSMUST00000228815.2 ENSMUST00000228198.2 ENSMUST00000227458.2 ENSMUST00000228232.2 ENSMUST00000227242.2 ENSMUST00000228748.2 |
Hnrnpc
|
heterogeneous nuclear ribonucleoprotein C |
chr1_+_92900834 | 1.38 |
ENSMUST00000186298.7
ENSMUST00000027489.9 |
Gpr35
|
G protein-coupled receptor 35 |
chr2_+_36120438 | 1.38 |
ENSMUST00000062069.6
|
Ptgs1
|
prostaglandin-endoperoxide synthase 1 |
chr13_-_35147771 | 1.38 |
ENSMUST00000164155.2
ENSMUST00000021853.12 |
Eci3
|
enoyl-Coenzyme A delta isomerase 3 |
chr14_+_32507920 | 1.38 |
ENSMUST00000039191.8
ENSMUST00000227060.2 ENSMUST00000228481.2 |
Tmem273
|
transmembrane protein 273 |
chr1_+_87983099 | 1.38 |
ENSMUST00000138182.8
ENSMUST00000113142.10 |
Ugt1a10
|
UDP glycosyltransferase 1 family, polypeptide A10 |
chr17_-_36149100 | 1.38 |
ENSMUST00000134978.3
|
Tubb5
|
tubulin, beta 5 class I |
chr19_-_57185928 | 1.38 |
ENSMUST00000111544.8
|
Ablim1
|
actin-binding LIM protein 1 |
chr8_-_58106057 | 1.37 |
ENSMUST00000034021.12
|
Galnt7
|
polypeptide N-acetylgalactosaminyltransferase 7 |
chr3_+_96552895 | 1.36 |
ENSMUST00000119365.8
ENSMUST00000029744.6 |
Itga10
|
integrin, alpha 10 |
chr6_-_69521891 | 1.35 |
ENSMUST00000103356.4
|
Igkv4-57-1
|
immunoglobulin kappa variable 4-57-1 |
chr2_+_118644675 | 1.35 |
ENSMUST00000110842.8
|
Knstrn
|
kinetochore-localized astrin/SPAG5 binding |
chr1_-_90897329 | 1.34 |
ENSMUST00000130042.2
ENSMUST00000027529.12 |
Rab17
|
RAB17, member RAS oncogene family |
chr15_+_7159038 | 1.34 |
ENSMUST00000067190.12
ENSMUST00000164529.9 |
Lifr
|
LIF receptor alpha |
chr14_-_122153185 | 1.34 |
ENSMUST00000055475.9
|
Gpr18
|
G protein-coupled receptor 18 |
chr10_-_111833138 | 1.33 |
ENSMUST00000074805.12
|
Glipr1
|
GLI pathogenesis-related 1 (glioma) |
chr2_+_74528071 | 1.33 |
ENSMUST00000059272.10
|
Hoxd9
|
homeobox D9 |
chr1_-_69726384 | 1.32 |
ENSMUST00000187184.7
|
Ikzf2
|
IKAROS family zinc finger 2 |
chrM_+_7779 | 1.31 |
ENSMUST00000082408.1
|
mt-Atp6
|
mitochondrially encoded ATP synthase 6 |
chr6_-_69584812 | 1.31 |
ENSMUST00000103359.3
|
Igkv4-55
|
immunoglobulin kappa variable 4-55 |
chr6_-_87815653 | 1.31 |
ENSMUST00000204431.2
ENSMUST00000089497.7 |
Isy1
|
ISY1 splicing factor homolog |
chr2_+_83554741 | 1.31 |
ENSMUST00000028499.11
|
Itgav
|
integrin alpha V |
chr6_-_71417607 | 1.30 |
ENSMUST00000002292.15
|
Rmnd5a
|
required for meiotic nuclear division 5 homolog A |
chr19_-_4240984 | 1.30 |
ENSMUST00000045864.4
|
Tbc1d10c
|
TBC1 domain family, member 10c |
chr17_-_36149142 | 1.30 |
ENSMUST00000001566.10
|
Tubb5
|
tubulin, beta 5 class I |
chr8_+_26298502 | 1.30 |
ENSMUST00000033979.6
|
Star
|
steroidogenic acute regulatory protein |
chr10_+_28544356 | 1.30 |
ENSMUST00000060409.13
ENSMUST00000056097.11 ENSMUST00000105516.9 |
Themis
|
thymocyte selection associated |
chr12_-_114955196 | 1.29 |
ENSMUST00000194865.2
|
Ighv1-47
|
immunoglobulin heavy variable 1-47 |
chr5_-_116162415 | 1.28 |
ENSMUST00000031486.14
ENSMUST00000111999.8 |
Prkab1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
chr3_+_90434160 | 1.28 |
ENSMUST00000199538.5
ENSMUST00000164481.7 ENSMUST00000167598.6 |
S100a14
|
S100 calcium binding protein A14 |
chr8_+_117648474 | 1.27 |
ENSMUST00000034205.5
ENSMUST00000212775.2 |
Cenpn
|
centromere protein N |
chr10_-_43934774 | 1.26 |
ENSMUST00000239010.2
|
Crybg1
|
crystallin beta-gamma domain containing 1 |
chr14_+_19801333 | 1.26 |
ENSMUST00000022340.5
|
Nid2
|
nidogen 2 |
chr13_+_38388904 | 1.25 |
ENSMUST00000091641.13
ENSMUST00000178564.2 |
Snrnp48
|
small nuclear ribonucleoprotein 48 (U11/U12) |
chr11_-_16958647 | 1.25 |
ENSMUST00000102881.10
|
Plek
|
pleckstrin |
chr5_-_137529465 | 1.25 |
ENSMUST00000150063.9
|
Gnb2
|
guanine nucleotide binding protein (G protein), beta 2 |
chr5_+_137015873 | 1.25 |
ENSMUST00000004968.11
|
Plod3
|
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
chr6_-_70051586 | 1.25 |
ENSMUST00000103377.3
|
Igkv6-32
|
immunoglobulin kappa variable 6-32 |
chr19_+_11514132 | 1.24 |
ENSMUST00000025581.7
|
Ms4a4d
|
membrane-spanning 4-domains, subfamily A, member 4D |
chr4_-_132056725 | 1.24 |
ENSMUST00000127402.8
ENSMUST00000105962.10 ENSMUST00000030730.14 ENSMUST00000105960.3 |
Trnau1ap
|
tRNA selenocysteine 1 associated protein 1 |
chr3_-_15902583 | 1.23 |
ENSMUST00000108354.8
ENSMUST00000108349.2 ENSMUST00000108352.9 ENSMUST00000108350.8 ENSMUST00000050623.11 |
Sirpb1c
|
signal-regulatory protein beta 1C |
chr5_-_65090893 | 1.23 |
ENSMUST00000197315.5
|
Tlr1
|
toll-like receptor 1 |
chr3_-_19319123 | 1.23 |
ENSMUST00000121951.2
|
Pde7a
|
phosphodiesterase 7A |
chr8_-_70962972 | 1.20 |
ENSMUST00000140679.8
ENSMUST00000129909.8 ENSMUST00000081940.11 |
Uba52
|
ubiquitin A-52 residue ribosomal protein fusion product 1 |
chrX_+_106299484 | 1.19 |
ENSMUST00000101294.9
ENSMUST00000118820.8 ENSMUST00000120971.8 |
Gpr174
|
G protein-coupled receptor 174 |
chr9_-_20871081 | 1.19 |
ENSMUST00000177754.9
|
Dnmt1
|
DNA methyltransferase (cytosine-5) 1 |
chr2_+_89642395 | 1.19 |
ENSMUST00000214508.2
|
Olfr1255
|
olfactory receptor 1255 |
chrX_+_158086253 | 1.18 |
ENSMUST00000112491.2
|
Rps6ka3
|
ribosomal protein S6 kinase polypeptide 3 |
chr16_+_33071784 | 1.18 |
ENSMUST00000023502.6
|
Snx4
|
sorting nexin 4 |
chr16_+_33504740 | 1.18 |
ENSMUST00000232568.2
|
Heg1
|
heart development protein with EGF-like domains 1 |
chr11_-_117670430 | 1.17 |
ENSMUST00000143406.8
|
Tmc6
|
transmembrane channel-like gene family 6 |
chr9_-_111086528 | 1.17 |
ENSMUST00000199404.2
|
Mlh1
|
mutL homolog 1 |
chr5_+_4073343 | 1.17 |
ENSMUST00000238634.2
|
Akap9
|
A kinase (PRKA) anchor protein (yotiao) 9 |
chr13_+_4624074 | 1.17 |
ENSMUST00000021628.4
|
Akr1c21
|
aldo-keto reductase family 1, member C21 |
chr4_-_123558516 | 1.16 |
ENSMUST00000147030.2
|
Macf1
|
microtubule-actin crosslinking factor 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.9 | GO:0072249 | metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
1.6 | 4.7 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
1.4 | 4.1 | GO:2000040 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.2 | 3.7 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
1.0 | 3.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.9 | 2.8 | GO:0090367 | negative regulation of mRNA modification(GO:0090367) |
0.9 | 2.8 | GO:2000536 | negative regulation of entry of bacterium into host cell(GO:2000536) |
0.8 | 4.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 2.2 | GO:0035874 | amiloride transport(GO:0015898) cellular response to copper ion starvation(GO:0035874) response to azide(GO:0097184) cellular response to azide(GO:0097185) |
0.7 | 2.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.7 | 2.0 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 1.8 | GO:1904753 | regulation of phenotypic switching(GO:1900239) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.5 | 1.6 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 3.8 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 2.1 | GO:0033379 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.5 | 2.1 | GO:0002859 | negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.5 | 2.0 | GO:0090118 | regulation of phosphatidylcholine catabolic process(GO:0010899) receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.5 | 2.9 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 1.4 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.5 | 1.9 | GO:0060382 | release from viral latency(GO:0019046) regulation of DNA strand elongation(GO:0060382) |
0.5 | 1.9 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.5 | 1.4 | GO:1904456 | negative regulation of neuronal action potential(GO:1904456) |
0.4 | 1.3 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.4 | 1.3 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.4 | 4.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.4 | 1.3 | GO:0000389 | generation of catalytic spliceosome for second transesterification step(GO:0000350) mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 1.3 | GO:0060305 | regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010924) positive regulation of inositol-polyphosphate 5-phosphatase activity(GO:0010925) phospholipase C-inhibiting G-protein coupled receptor signaling pathway(GO:0030845) regulation of cell diameter(GO:0060305) |
0.4 | 2.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.4 | 1.2 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) |
0.4 | 0.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.4 | 1.2 | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) |
0.4 | 1.2 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.4 | 0.8 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.4 | 1.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.4 | 1.4 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.3 | 1.0 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.3 | 1.0 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.3 | 1.7 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 1.0 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.3 | 1.6 | GO:0002159 | desmosome assembly(GO:0002159) |
0.3 | 5.6 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.3 | 2.8 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 0.9 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.3 | 0.9 | GO:0044240 | negative regulation of lipoprotein oxidation(GO:0034443) multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 0.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.2 | GO:0090309 | C-5 methylation of cytosine(GO:0090116) positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 1.2 | GO:0003017 | lymph circulation(GO:0003017) |
0.3 | 1.2 | GO:0043060 | meiotic metaphase I plate congression(GO:0043060) meiotic metaphase plate congression(GO:0051311) |
0.3 | 3.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 0.8 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.3 | 2.7 | GO:0060339 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 5.4 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.3 | 1.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 1.3 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 0.8 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 1.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 1.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 1.0 | GO:0015744 | succinate transport(GO:0015744) |
0.2 | 2.9 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 0.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 1.4 | GO:0035633 | cyclooxygenase pathway(GO:0019371) maintenance of blood-brain barrier(GO:0035633) |
0.2 | 5.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 2.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.9 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.2 | 1.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 1.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 3.4 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 0.4 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 1.0 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 0.4 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.2 | 1.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 1.4 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.2 | 0.6 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 1.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.8 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.2 | 1.3 | GO:0048861 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 4.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.6 | GO:1904156 | DN2 thymocyte differentiation(GO:1904155) DN3 thymocyte differentiation(GO:1904156) |
0.2 | 0.9 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 1.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 1.3 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.2 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) positive regulation of t-circle formation(GO:1904431) |
0.2 | 2.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.5 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.2 | 0.5 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
0.2 | 0.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 0.7 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.2 | 1.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 1.6 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 0.5 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 0.5 | GO:0036245 | cellular response to menadione(GO:0036245) |
0.2 | 1.9 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.5 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.2 | 0.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.9 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.4 | GO:0000393 | generation of catalytic spliceosome for first transesterification step(GO:0000349) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 1.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 1.0 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.1 | 0.6 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.5 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.4 | GO:0061623 | glycolytic process from galactose(GO:0061623) |
0.1 | 4.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 2.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 1.2 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.4 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 3.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 20.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 2.0 | GO:0043383 | negative T cell selection(GO:0043383) |
0.1 | 1.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.7 | GO:0090656 | t-circle formation(GO:0090656) |
0.1 | 0.5 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
0.1 | 30.8 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.1 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
0.1 | 1.0 | GO:0031179 | peptide modification(GO:0031179) |
0.1 | 0.6 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 4.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 2.1 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 1.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.4 | GO:0072355 | histone H3-T3 phosphorylation(GO:0072355) |
0.1 | 2.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 2.5 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.1 | 1.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.4 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 1.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) diacylglycerol catabolic process(GO:0046340) |
0.1 | 2.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 3.1 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.5 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.1 | 0.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 1.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.1 | 0.3 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) negative regulation of chronic inflammatory response(GO:0002677) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.1 | 0.5 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 0.5 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.1 | 0.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.3 | GO:0009814 | defense response, incompatible interaction(GO:0009814) defense response to bacterium, incompatible interaction(GO:0009816) regulation of defense response to bacterium, incompatible interaction(GO:1902477) |
0.1 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 1.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.7 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 1.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.3 | GO:0070537 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) histone H2A K63-linked deubiquitination(GO:0070537) |
0.1 | 0.5 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) |
0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:0021589 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.1 | 2.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 1.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 2.9 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.4 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.1 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 2.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 1.1 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
0.1 | 1.8 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 1.0 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.1 | 1.4 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 1.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.5 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.1 | GO:0061193 | taste bud development(GO:0061193) |
0.1 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.8 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 2.5 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 1.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 2.9 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 0.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.1 | 0.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 1.6 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
0.1 | 1.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.8 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 2.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.2 | GO:0019344 | cysteine biosynthetic process from serine(GO:0006535) cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
0.0 | 1.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.3 | GO:0044334 | canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.7 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.5 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 1.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 4.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.1 | GO:0009826 | mesoderm migration involved in gastrulation(GO:0007509) unidimensional cell growth(GO:0009826) |
0.0 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 1.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 1.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 1.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.6 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.0 | 0.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.0 | 1.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 0.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 1.9 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.0 | 2.7 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.0 | 0.1 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 3.4 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.1 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 1.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 1.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 2.7 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 1.0 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 1.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.4 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.2 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 1.7 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.0 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 1.0 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 1.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.0 | 1.2 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.8 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 1.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.6 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 2.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.2 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 1.0 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
0.0 | 0.1 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 6.0 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 0.5 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 2.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 1.4 | GO:0061180 | mammary gland epithelium development(GO:0061180) |
0.0 | 1.4 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.4 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 1.4 | GO:0072163 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.0 | 0.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.7 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.0 | 0.0 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 1.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.3 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 3.8 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 2.0 | GO:0007369 | gastrulation(GO:0007369) |
0.0 | 0.2 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.3 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.3 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 1.5 | GO:0031109 | microtubule polymerization or depolymerization(GO:0031109) |
0.0 | 0.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 1.4 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.0 | 0.2 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 1.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 6.0 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.7 | 2.1 | GO:0060187 | cell pole(GO:0060187) |
0.7 | 8.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.7 | 2.8 | GO:0034686 | integrin alphav-beta3 complex(GO:0034683) integrin alphav-beta8 complex(GO:0034686) |
0.7 | 2.0 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.5 | 2.4 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.5 | 1.4 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.4 | 5.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 2.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.4 | 1.2 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.4 | 1.2 | GO:0005712 | chiasma(GO:0005712) late recombination nodule(GO:0005715) |
0.4 | 1.5 | GO:0008623 | CHRAC(GO:0008623) |
0.3 | 1.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 2.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.3 | 0.8 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.3 | 4.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 3.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.3 | 1.3 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 3.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.9 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 1.2 | GO:0044307 | dendritic branch(GO:0044307) |
0.2 | 0.2 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 2.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.1 | GO:1990462 | omegasome(GO:1990462) |
0.2 | 3.0 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 3.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 1.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 2.0 | GO:0032797 | SMN complex(GO:0032797) |
0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 1.8 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 18.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 1.0 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 1.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.0 | GO:0097422 | extrinsic component of endosome membrane(GO:0031313) tubular endosome(GO:0097422) |
0.1 | 4.3 | GO:1990752 | microtubule plus-end(GO:0035371) microtubule end(GO:1990752) |
0.1 | 0.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 2.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 1.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 5.5 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 9.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 1.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 2.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 1.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 1.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 7.3 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 5.6 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.9 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.3 | GO:0035841 | new growing cell tip(GO:0035841) |
0.1 | 0.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 0.5 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 2.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.7 | GO:0045275 | respiratory chain complex III(GO:0045275) |
0.1 | 4.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.7 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 1.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.0 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 1.0 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 1.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 3.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 2.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 2.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 1.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 5.2 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.9 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 2.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.8 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.0 | 2.0 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 1.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 2.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 1.2 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 7.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 8.2 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.5 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 1.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 2.6 | GO:0016605 | PML body(GO:0016605) |
0.0 | 2.7 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.0 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.5 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 4.6 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.5 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 1.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 2.3 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 8.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 6.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.8 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.2 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 23.6 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 1.1 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 1.2 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.0 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 0.7 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.3 | GO:0000792 | heterochromatin(GO:0000792) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.7 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
1.2 | 4.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.7 | 2.2 | GO:0052598 | diamine oxidase activity(GO:0052597) histamine oxidase activity(GO:0052598) methylputrescine oxidase activity(GO:0052599) propane-1,3-diamine oxidase activity(GO:0052600) |
0.5 | 3.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.5 | 5.0 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 1.8 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 4.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 2.6 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.4 | 1.2 | GO:0042497 | triacyl lipopeptide binding(GO:0042497) |
0.4 | 1.2 | GO:1902121 | NADP+ binding(GO:0070401) lithocholic acid binding(GO:1902121) |
0.4 | 2.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 1.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 3.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 1.0 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.3 | 0.9 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.3 | 4.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 1.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 1.2 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.3 | 1.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 1.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 1.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.3 | 1.3 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.3 | 0.8 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 0.8 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.3 | 0.8 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.2 | 1.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 2.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 4.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 2.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 4.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.6 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
0.2 | 4.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.6 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.2 | 4.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 0.8 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.2 | 6.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.6 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.2 | 1.7 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 1.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.7 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 2.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 1.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 2.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 2.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.4 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.1 | 0.8 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 18.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 3.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 1.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 1.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.4 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
0.1 | 1.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 2.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 1.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.4 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.1 | 0.4 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 2.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.1 | 3.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.1 | 1.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.9 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 2.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.8 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 1.4 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.5 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 6.4 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 2.7 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.5 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 2.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.1 | 0.6 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.7 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0052692 | raffinose alpha-galactosidase activity(GO:0052692) |
0.1 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 0.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 6.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.1 | 1.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 1.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 1.4 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 1.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 2.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.1 | 0.8 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 5.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.2 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitric oxide binding(GO:0070026) |
0.1 | 0.5 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 2.0 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 1.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 2.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 3.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 2.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 1.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 1.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 1.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.4 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.0 | 0.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 4.3 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 1.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 2.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 1.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 2.1 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.6 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 1.7 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 3.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.0 | 0.9 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.0 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 1.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.5 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 1.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 3.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 2.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 1.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 1.6 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 3.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 1.0 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.2 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 1.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 0.1 | GO:0001164 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 3.3 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.9 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 4.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 6.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 4.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 5.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 5.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.0 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 5.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 3.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 4.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 6.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 0.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.2 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 3.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 1.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 2.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 3.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 2.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 2.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 2.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 2.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 4.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.9 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 4.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 1.1 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 4.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 8.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 1.8 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 4.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 2.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 1.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 4.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 3.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 4.8 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 2.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 10.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 3.7 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 1.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.0 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 2.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 1.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 2.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 3.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 0.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 5.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 5.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 2.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 1.2 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 1.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 2.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 5.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 1.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 1.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 3.6 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 1.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 1.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 3.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 1.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 3.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.9 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |